AGIO:NASDAQ
Agios Pharmaceuticals Inc
29,89 $
arrow_downward
-0,86%(-0,26) 1D
29,89 $
0,00% (0,00)
bedtimeAfter hours
Closed: 17 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
30,09 $
High
30,38 $
Low
28,94 $
Mkt. cap
1,79 մլրդ
Avg. vol.
1,23 մլն
Volume
0,00
52-wk high
45,99 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
Open
30,09 $
High
30,38 $
Low
28,94 $
Mkt. cap
1,79 մլրդ
Avg. vol.
1,23 մլն
Volume
0,00
52-wk high
45,99 $
52-wk low
22,24 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 մլն
No. of employees
540
News stories
From web sources and news partners
Benzinga
·
28 րոպե առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
Latest news from Azerbaijan
·
3 րոպե առաջ
Dow, S&P 500, Nasdaq futures extend losses for fourth session amid AI sell-off
BigGo Finance
·
9 ժամ առաջ
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Traders Union
·
5 ժամ առաջ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc